Biognosys is the leading proteomics company offering innovative services and products for highly multiplexed protein quantification.
Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys is dedicated to transforming the life sciences with next generation proteomics solutions.
Biognosys believes that the decoding of the proteome will impact the life sciences more than the genome revolution two decades ago. Biognosys’ next generation technology quantifies proteins with unbeatable precision and depth. Our solution relies on mass spectrometry, which allows simultaneous quantification of thousands of proteins in a single experiment. This new generation protein quantification technology is available to researchers worldwide through our contract research services or our portfolio of innovative reagent and software products.